Hepatoprotective effect of lactic acid bacteria

Journal of Microbiology and Biotechnology

Volumn 15, Issue 4, 2005, Pages 887-890

  Han, Song Yi ^b   Huh, Chul Sung ^a   Ahn, Young Tae ^a   Lim, Kwang Sei ^a   Baek, Young Jin ^a   Kim, Dong Hyun ^b  

^a Korea Yakult Co   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Hepatoprotective; HepG2; Lactic acid bacteria; Tert butyl hydroperoxide

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBOXYLIC ACID DERIVATIVE; DIPHENYLDIMETHYLBICARBOXYLATE; LIPID; PROBIOTIC AGENT; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL STRAIN; BIFIDOBACTERIUM LONGUM; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; LACTIC ACID BACTERIUM; LIPID PEROXIDATION; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; NONHUMAN;

BIFIDOBACTERIUM LONGUM;

EID: 24644500228     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Adachi, S. 1992. Lactic acid bacteria and the control of tumors, pp. 233-261. In Wood, B. J. B. (ed.), The Lactic Acid Bacteria, vol. 1. Elsevier Science Publishers, Ltd., Essex.
2. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72: 248-254.
3. Breimer, L. H. 1990. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: The role of DNA base damage. Mol. Carcinog. 3: 188-197
4. Carmichael, J., W. G. DeGreff, A. F. Gazdar, J. D. Minna, and J. B. Mitchell. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res. 47: 936-940.
5. Campieri, M. and P. Gionchetti. 1999. Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative. Gastroenterology 116: 1246-1260.
6. Ceryttu, P. A. 1985. Prooxidant states and tumor promotion. Science 227: 375-381.
7. Chang, H. A., K. H. Choi, T. K. Oh, A. R. Kown, D. H. Kim, and E. C. Choi. 1998. Antibiotic susceptibility of Bifidobacterium spp. strains isolated from healthy Korean. Yakhak Hoeji 42: 639-641.
8. Collins, M. P. and G. R. Gibson. 1999. Probiotics, prebiotics, and synbiotics: Approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 69: s1052-s1057.
9. Cross, M. L., L. M. Stevenson, and H. S. Gill. 2001. Antiallergy properties of fermented foods: An important immunoregulatory mechanism of lactic acid bacteria? Intern. Immunopharmacol. 1: 891-901.
10. Gilliland, S. E., C. R. Nelson, and C. Maxwell. 1985. Assimilation of cholesterol by Lactobacillus acidophilus. Appl. Environ. Microbiol. 49: 377-381.
11. Goldin, B. and S. L. Gorbach. 1976. The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. J. Natl. Cancer Inst. 57: 371-375.
12. Han, M. J., H. Y. Park, and D.-H. Kim. 1999. Protective effects of Bifidobacterium spp. on experimental colon carcinogenesis with 1,2-dimethylhydrazine. J. Microbiol. Biotechnol. 9: 368-370.
13. Hepner, G., R. Fried, S. St. Jeor, L. Fusetti, and R. Morin. 1979. Hypocholesterolemic effect of yogurt and milk. Am. J. Clin. Nutr. 32: 19-24.
14. Joyeux, M., A. Rolland, J. Fleurentin, F. Mortier, and P. Dorfman. 1990. tert-Butyl hydroperoxide-induced injury in isolated rat hepatocytes: A model for studying antihepatotoxic crude drugs. Planta Med. 56: 171-174.
15. Kim, J.-H., H.-J. Kim, J. H. Son, H.-N. Chun, J.-O. Yang, S.-J. Choi, N.-S. Paek, G.-H. Choi, and S.-K. Kim. 2003. Effect of Lactobacillus fermentum MG590 on alcohol metabolism and liver function in rats. J. Microbiol. Biotechnol. 13: 919-925.
16. Kim, I. H., M. S. Park, and G. E. Ji. 2003. Characterization of adhesion of Bifidobacterium sp. BGN4 to human enterocyte-like Caco-2 cells. J. Microbiol. Biotechnol. 14: 276-281.
17. Lee, H.-H., J.-H. Park, S.-H. Seok, S.-A. Cho, M.-W. Baek, D.-J. Kim, Y.-H. Lee, and J.-H. Park. 2004. Dietary intake of various lactic acid bacteria suppresses type 2 helper T cell production in antigen-primed mice splenocyte. J. Microbiol. Biotechnol. 14: 167-170.
18. Mann, G. V. 1977. A factor in yogurt which lowers cholesterolemia in man. Arterosclerosis 26: 335-340.
19. Okhawa, H., N. Ohishi, and K. Yaki. 1979. Assay for lipid peroxides in animal tissues by thibarbituric acid reaction. Anal. Biochem. 95: 35-41.
20. Park, H.-Y., E. A. Bae, M. J. Han, E. C. Choi, and D.-H. Kim. 1998. Inhibitory effects of Bifidobacterium spp. isolated from a healthy Korean on harmful enzymes of human intestinal microflora. Arch. Pharm. Res. 21: 54-61.
21. Perdigon, G., W. E. B. de Jorrat, S. F. de Petrino, and M. Valerde de Budeguer. 1991. Effect of oral administration of Lactobacillus casei on various biological functions of the host. Food Agric. Immunol. 3: 93-102.
22. Reddy, B. S., A. Mastromarini, and E. Wynder. 1977. Diet and metabolism: Large bowel cancer. Cancer 39: 1815-1819.
23. Reitman, S. and S. Frankel. 1957. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. Am. J. Clin. Path. 28: 56-63.
24. Rodas, B. Z., S. E. Gilliland, and C. V. Maxwell. 1996. Hypocholesterolemic action of Lactobacillus acidophilus ATCC43121 and calcium in swine with hypercholesterolemia induced by diet. J. Dairy Sci. 79: 2121-2128.
25. Salminen, S., L. Deighton, and S. Gorbach. 1974. Lactic acid bacteria in health and disease, pp. 199-226. In Salminen, S. and von Wright, A. (eds.), Lactic Acid Bacteria. Marcel Dekker, Inc., New York, U.S.A.
26. Shin, I. C. and H. C. Koh. 1995. Effects of biphenyldimethyl dicarboxylate (DDB) on the lipid peroxidation and oxygen free radical scavenging enzyme activities in mercuric chloride-induced hepatotoxic rats. J. Appl. Pharmacol. 3: 223-228.
27. Tabuchi, M., M. Ozaki, A. Tamura, N. Yamada, T. Ishida, M. Hosoda, and A. Hosono. 2003. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci. Biotechnol. Biochem. 67: 1421-1424.
28. Taranto, M. P., M. Medici, G. Perdigon, A. P. Ruiz Holgado, and G. F. Valdez. 1998. Evidence for hypoglycemic effect of Lactobacillus reuteri in hypercholesterolemic mice. J. Dairy Sci. 81: 2336-2340.
29. Wang, W. L. 1984. Clinical effect of DDB piles on 56 cases of chronic viral hepatitis B. New Drugs Clinic 3: 13-15.